Ex­sci­en­tia to col­lab­o­rate with Ox­ford's Alzheimer's cen­ter; Dana-Far­ber en­lists Reper­toire for head and neck can­cer

The AI out­fit Ex­sci­en­tia has forged a col­lab­o­ra­tion with the Alzheimer’s Re­search UK Uni­ver­si­ty of Ox­ford Drug Dis­cov­ery In­sti­tute to de­vel­op new drugs aimed at tam­ing the mem­o­ry-wast­ing ail­ment by tar­get­ing neu­roin­flam­ma­tion.

The part­ners high­light­ed the in­flam­ma­to­ry role of NL­RP3 in their state­ment, high­light­ing an in­flam­ma­some that has in­spired a few star­tups in re­cent years.

They’ll be work­ing to­geth­er to screen new drug can­di­dates, look­ing for a break­through in a field that so far has frus­trat­ed vir­tu­al­ly every de­vel­op­er which has giv­en it a try in the last 20 years or so.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER